Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
EarthEcho International Empowers Youth to Lead the Way in Protecting Local Ecosystems and Restoring Biodiversity
-
CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia
-
Orca Energy Group Inc. Announces Prepayment of International Finance Corporation Loan, Settlement of Supplementary Gas Sales Agreement and Judgment of the Tanzanian High Court
-
Scale Biosciences Launches Five Single Cell Profiling Products, Unlocking Single Cell RNA Studies at Any Scale
-
Halda Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial Evaluating HLD-0915 in Metastatic Castration-Resistant Prostate Cancer
-
“It Was Like Something Out of a Wild West Movie”: 4Patriots Offers $10,000 Reward to Find “Power Thieves” Who Stole 112 of Its Latest-model Solar Generators in Brazen Train Robbery Outside Atl
-
SysAid Enhances AI-Driven ITAM with Advanced Discovery, Powered by Partnership with Lansweeper
-
Iron Mountain to Present at Financial Conference
-
Transportation at a Crossroads: Breakthrough Research Reveals How Shippers Are Balancing Sustainability With Cost Efficiency
-
Basic Fun! Stretches the Limits with New STRETCH ARMSTRONG Toy Line
-
BioStem Receives Institutional Review Board (IRB) Approval to Advance Clinical Trial Demonstrating the Therapeutic Benefits of BioREtain® Technology in Treating Venous Leg Ulcers
-
AN2 Provides Strategic Update for Phase 3 EBO-301 Trial in Treatment Refractory MAC Lung Disease
-
PepGen Announces Positive Initial Results, Including Robust Splicing Correction, from Ongoing FREEDOM-DM1 Trial in Patients with DM1
-
Complete Genomics unveils DNBSEQ-T1+ and DNBSEQ-E25 Flash at AGBT 2025 General Meeting
-
Seeing Machines names Mitsubishi Electric Automotive America as a referral partner to drive accelerated sales of Guardian Generation 3 in The Americas
-
QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference
-
Unity Announces Proposed $500.0 Million Offering of Convertible Senior Notes
-
Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors
-
NMG to Present at BMO’s Global Metals, Mining and Critical Minerals Conference
-
Bruker Advances Single-Cell Proteomics and Immunopeptidomics Performance; Unveils New Proteomics Software and Applications for Enhanced Biological Insights at US HUPO
-
ez1095 ACA Software Offers Video Instructions for Upcoming Efile Deadlines
-
Aeva Announces Date for Fourth Quarter and Full Year 2024 Results and Conference Call
-
Volato Begins Bitcoin Mining, Targets Citation CJ Series for First Aviation-Based Crypto Mining Platform
-
Over 2,000 School Support Workers Join Strike Today
-
United Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care Conference
-
Nektar Announces Clinical Trial Agreement to Evaluate Rezpegaldesleukin in Patients with New Onset Type 1 Diabetes Mellitus
-
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
-
Newly Formed Stronvar Aerospace Announces Acquisition of Electro Methods Inc., Investment from Blackstone
-
OXIO Appoints Robb Robinson as SVP of Sales and Channels to Fuel Expansion Across the U.S.
-
WeRide’s Latest Robotaxi GXR to Start First Fully Unmanned Commercial Operations in Beijing
-
BirdseyePost Unveils Penny©, a Fully Autonomous AI Agent for Scalable, Data-Driven Marketing Across Print and Digital
-
Cullinan Therapeutics to Participate in Upcoming Investor Conferences
-
iHerb Surpasses $2.4 Billion in Sales, Solidifying Leadership in Global Health and Wellness
-
Axsome Therapeutics Announces SYMBRAVO® (meloxicam and rizatriptan) Achieves Primary Endpoint in the EMERGE Phase 3 Trial in Migraine Patients Experiencing Inadequate Response to Oral CGRP Inhibitors
-
Rapport Therapeutics to Participate in Upcoming Investor Conferences
-
Syndax to Announce Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call and Webcast on March 3, 2025
-
Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer
-
Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives
-
OTC Markets Group Welcomes ZRCN Inc. to OTCQX
-
Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
-
Beam Therapeutics to Participate in Upcoming March 2025 Investor Conferences
-
PyroGenesis Signs $2.4 Million Contract with Norsk Hydro ASA
-
Latus Bio Announces Data Presentations in Support of its Preclinical Huntington’s Disease Gene Therapy Program
-
OTC Markets Group Welcomes Anaergia Inc. to OTCQX
-
CareCloud to Announce Fourth Quarter and Full Year 2024 Results on March 13, 2025
-
C4 Therapeutics to Participate in Upcoming March Investor Conferences
-
Entrada Therapeutics Announces FDA Removal of Clinical Hold on ENTR-601-44
-
Fractyl Health to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 3, 2025
-
Avalo Therapeutics to Participate in Upcoming Investor Conferences
-
Signify share repurchase period update

